“Efficacy of Halobetasol 0.01% Tazarotene 0.045% (HP TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP TAZ and Oral Treatment (Apremilast)”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S30, https://doi.org/10.25251/skin.3.supp.30.